Filter
1074
Filtered Results: 1074
Text search:
Y.
Ono
Featured
Recommendations
92
New Publications
195
Language
Document type
No document type
407
Guidelines
298
Studies & Reports
158
Manuals
83
Strategic & Response Plan
58
Training Material
26
Fact sheets
24
Brochures
8
Situation Updates
6
Infographics
4
App
1
Resource Platforms
1
Countries / Regions
Latin America and the Carribbean
90
Paraguay
72
Venezuela
54
Argentina
50
Colombia
49
Global
36
Peru
27
Chile
24
Bolivia
23
Ecuador
22
El Salvador
18
Nigeria
16
Spain
13
Western and Central Europe
11
Senegal
10
Kenya
10
Brazil
10
Africa
10
Zambia
9
Uganda
8
Malawi
7
West and Central Africa
7
Congo, Democratic Republic of
6
India
6
Mozambique
6
Ukraine
6
Myanmar / Burma
6
East and Southern Africa
6
Burkina Faso
5
Germany
5
Rwanda
5
Mexico
5
Eastern Europe
5
Philippines
4
South Sudan
4
Syria
4
Guatemala
4
Middle East and North Africa
4
South–East Asia Region
4
Sierra Leone
3
Haiti
3
South Africa
3
Honduras
3
Angola
3
Nicaragua
3
Eastern Europe and Central Asia
3
Russia
3
Uruguay
3
Guinea-Bissau
2
Ethiopia
2
Ghana
2
Nepal
2
Afghanistan
2
Tanzania
2
Indonesia
2
Bangladesh
2
Benin
2
Dominican Republic
2
Madagascar
2
Western Pacific Region
2
Asia
2
Moldova
2
Liberia
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Cameroon
1
Zimbabwe
1
Somalia
1
Pakistan
1
Cambodia
1
Thailand
1
Central African Republic
1
Austria
1
Switzerland
1
Cuba
1
Burundi
1
Botswana
1
Libya
1
Yemen
1
Palestine
1
Armenia
1
Tajikistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Mauritius
1
United Kingdom
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
503
Clinical Guidelines
91
Women & Child Health
55
Public Health
43
Key Resources
32
Pharmacy & Technologies
13
Capacity Building
9
Toolboxes
COVID-19
204
TB
129
Mental Health
111
AMR
40
HIV
36
Planetary Health
32
NTDs
31
Disability
28
Rapid Response
28
Caregiver
28
Pharmacy
23
Conflict
20
Zika
15
Cholera
12
Refugee
10
Global Health Education
10
NCDs
10
Ebola
7
Natural Hazards
6
Polio
5
Social Ethics
5
Specific Hazards
2
Health Financing Toolbox
2
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
Algorithm for COVID-19 triage and referral
recommended
Efficient triage of patients with COVID-19 at all health facility levels (primary, secondary and tertiary) will help the national response planning and case management system cope with patient influx, direct necessary medical resources to efficiently support the critically ill and protect the safety...
The Feedback Starter-Kit responds to key questions ( ) and provides the most important tips ( ) for setting up and running a simple feedback mechanism. At the end of this document there is an overview of the templates needed to plan the mechanism and collect, answer, analyse and share community feed...
Geographical Paper No. 177
Accessed on: 18.06.2020
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The document includes recommendations for methods for ...
Le suivi évaluation des interventions en santé passe par une meilleure lisibilité de l’analyse situationnelle. Une capitalisation du niveau d’atteintes des indicateurs est nécessaire pour traduire la situation sanitaire. Le présent tableau de bord de santé décrit cette situation à traver...
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
This report presents examples from different agencies on how they approached community engagement in their Covid-19 responses, the tools and methodologies used, as well as the challenges they encountered and how they attempted to overcome these. It discusses what community engagement means to the va...
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
Concentrations of the major greenhouse gases, CO2 , CH4 , and N2 O, continued to increase despite the temporary reduction in emissions in 2020 related to measures taken in response to COVID-19.
2020 was one of the three warmest years on record. The past six years, including 2020, have been the si...
The WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination is intended to offer guidance on the prioritization of groups for vaccination when vaccine supply is limited. It provides a values foundation for the objectives of COVID-19 vaccination programmes and links t...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Um Manual Passo A Passo
Background paper 9
The Independent Panel for Pandemic Preparedness and Response
May 2021
